Effect of hyperbaric oxygen combined with Memantine Hydrochloride in the treatment of dementia patients with Parkinson′s disease
PENG Wei1 SONG Hai2 WANG Yu-mei1 ZHOU Hua-jun3
1.Department of Neurology,Wuwei People′s Hospital
2.Medical Transfer Office,Wuwei People′s Hospital
3.Institute of Neurology,the First Clinical Medical College of Three Gorges University
Abstract:Objective To analyze the effect of hyperbaric oxygen combined with Memantine Hydrochloride in the treatment of dementia patients with Parkinson′s disease (PD).Methods A total of 68 patients with PD and dementia diagnosed in Wuwei People′s Hospital,Gansu Province from January to December 2019 were selected.They were divided into the control and the observation group according to random number table method,34 cases in each group.The patients in the control group were treated with Memantine alone,and the patients in the observation group were treated with hyperbaric oxygen combined with Memantine Hydrochloride.The therapeutic effects of the two groups and the adverse reactions during treatment were compared..Results After treatment,the scores of the simple mental state scale(MMSE) and the Montreal cognitive assessment scale (MOCA) in the observation group and the control group were improved,but the MMSE,MOCA scores in the observation group were higher than those in the control group,the differences were statistically significant (P<0.05).There were 1 case of nausea and 2 cases of dizziness in the observation group,which were significantly improved after the intervention of symptomatic treatment measures.There was no statistically significant difference in the total incidence of adverse reactions between the control group and the observation group (P>0.05).Conclusion Memantine Hydrochloride is safe and feasible in the treatment of senile dementia with PD,which can effectively improve cognitive function and imprave daily self-care ability.
彭炜;宋海;王玉梅;周华军. 高压氧联合盐酸美金刚治疗帕金森病痴呆患者的效果[J]. 中国当代医药, 2020, 27(36): 37-39转55.
PENG Wei;SONG Hai; WANG Yu-mei;ZHOU Hua-jun. Effect of hyperbaric oxygen combined with Memantine Hydrochloride in the treatment of dementia patients with Parkinson′s disease. 中国当代医药, 2020, 27(36): 37-39转55.
Boysen G,Brander T,Christensen H,et al.Homocysteine and risk of recurrent stroke[J].Stroke,2003,34(5):1258-1261.
[4]
Battle DE.Diagnostic and statistical manual of mental disorders[J].Codas,2013,25(2):191-192.
[5]
van den Heuvel DM,Admiraal-Behlonl F,ten Dam VH,et al.PROSPER study group.Different progression rates for deep whitematter hyperintensities in elderly nlen and wolnen[J].Neurology,2004,63(9):1699-1701.
[6]
Petitti DB,Sideny S,Bernstein A,et al.Stroke in users of low-dose oral contraceptives[J].N Engl J Med,1996,335(1):8-15.
Devos D,Moreau C,Maltete D,et al.Rivastigmine in apathetic but dementia and depression-free patients with Parkinson′s disease:a double-blind,placebo-controlled,randomised clinical trial[J].J Neurol,Neurolosurg Psychiatry,2014,85(6):668-674.
Simoni M,Li L,Paul NL,et al.Age-and sex-specific rates of leukoaraiosis in TIA and stroke patients Populationbased study[J].Neurology,2012,79(12):1215-1222.
Liu YH,You Y,Song T,et al.Impairment of endothelium dependentrelaxation of rat aortas by homocysteinc thiolactoneand attenuationby eaptopril[J].Cardiovasc Pharmacol,2014,50(3):155-161.